80 FR 25692 - World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC or Advisory Committee), National Institute for Occupational Safety and Health (NIOSH)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 86 (May 5, 2015)

[Federal Register Volume 80, Number 86 (Tuesday, May 5, 2015)]
[Notices]
[Pages 25692-25693]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-10418]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2015-0026; NIOSH 248-B]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Time and Date: 10:00 a.m.-4:45 p.m., June 4, 2015 (All times are 
Eastern Daylight Savings Time).
    Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278. This meeting is also available by 
teleconference. The USA toll-free, dial-in number is 1-888-810-6754, 
and when prompted enter passcode--1908415. To view the web 
conference, enter the following web address in your web browser: 
https://odniosh.adobeconnect.com/wtcstacjune4/.
    Public Comment Time and Date: 1:30 p.m.-2:00 p.m., June 4, 2015.
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever 
is earlier. Members of the public who want to comment must sign up 
by providing their name by mail, email, or telephone, at the 
addresses provided below by May 29, 2015. Each commenter will be 
provided up to five minutes for comment. A limited number of time 
slots are available and will be assigned on a first come, first 
served basis. Written comments will also be accepted from those 
unable to attend the public session.
    Status: Open to the public, limited only by the number of 
telephone lines. The conference line will accommodate up to 100 
callers; therefore it is suggested that those interested in calling 
in to listen to the committee meeting share a line when possible.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 
2, 2011 and codified at 42 U.S.C. 300mm-300mm-61.

[[Page 25693]]

    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
Administrator of the World Trade Center (WTC) Health Program 
regarding additional WTC Health Program eligibility criteria and 
potential additions to the list of covered WTC-related health 
conditions, as well as providing consultation on research to the 
Administrator of the World Trade Center Health Program. Title XXXIII 
of the Public Health Service Act established within the Department 
of Health and Human Services (HHS), the World Trade Center (WTC) 
Health Program, to be administered by the Administrator of the World 
Trade Center Health Program. The WTC Health Program provides: (1) 
Medical monitoring and treatment benefits to eligible emergency 
responders and recovery and cleanup workers (including those who are 
Federal employees) who responded to the September 11, 2001, 
terrorist attacks, and (2) initial health evaluation, monitoring, 
and treatment benefits to residents and other building occupants and 
area workers in New York City, who were directly impacted and 
adversely affected by such attacks (``survivors''). Certain specific 
activities of the Administrator of the World Trade Center Health 
Program are reserved to the Secretary, HHS, to delegate at her 
discretion; other duties of the Administrator of the World Trade 
Center Health Program not explicitly reserved to the Secretary, HHS, 
are assigned to the Director, NIOSH. The administration of the 
Advisory Committee established under section 300mm-1(a) is delegated 
to the Director of NIOSH in his role as Administrator of the World 
Trade Center Health Program. CDC and NIOSH provide funding, 
staffing, and administrative support services for the Advisory 
Committee. The charter was reissued on May 12, 2013, and will expire 
on May 12, 2015. The charter renewal is currently in process.
    Matters for Discussion: The agenda for the Advisory Committee 
meeting includes a review of the World Trade Center Health Program's 
(WTCHP) structure and function, activities, member services, and 
communications. An overview of the WTC health research, the WTC 
Registry, and lessons learned in addressing WTC-related mental 
health issues will also be presented. The Advisory Committee will 
deliberate on specific questions related to: (1) Addressing the need 
for research on developmental or health effects in children; (2) 
developing robust and appropriate comparison groups to improve the 
validity and interpretability of WTC research; (3) improving 
benefits counseling and psychosocial support for members serviced by 
the National Provider Network; and (4) reviewing the WTCHP's 
``Research-to-Care'' model.
    The agenda is subject to change as priorities dictate.
    To view the notice, visit http://www.regulations.gov and enter 
CDC-2015-0026 in the search field and click ``Search.''
    Public Comment Sign-up and Submissions to the Docket: To sign up 
to provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following 
means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
1090 Tusculum Avenue, Cincinnati, Ohio 45226.
    Email: [email protected].
    Telephone: (513) 533-8611.
    In the event an individual cannot attend, written comments may 
be submitted. The comments should be limited to two pages and 
submitted through http://www.regulations.gov by May 29, 2015. 
Efforts will be made to provide the two-page written comments 
received by the deadline below to the committee members before the 
meeting. Comments in excess of two pages will be made publicly 
available at http://www.regulations.gov. To view background 
information and previous submissions go to NIOSH docket http://www.cdc.gov/niosh/docket/archive/docket248.html and http://www.cdc.gov/niosh/docket/archive/docket248-A.html.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives his or her name, no attempt will be made to 
redact that name. NIOSH will take reasonable steps to ensure that 
individuals making public comments are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public Web site. Such 
reasonable steps include a statement read at the start of the 
meeting stating that transcripts will be posted and names of 
speakers will not be redacted. If individuals in making a statement 
reveal personal information (e.g., medical information) about 
themselves, that information will not usually be redacted. The CDC 
Freedom of Information Act coordinator will, however, review such 
revelations in accordance with the Freedom of Information Act and, 
if deemed appropriate, will redact such information. Disclosures of 
information concerning third party medical information will be 
redacted.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., 
Mail Stop E-20, Atlanta, Georgia 30345, telephone 1 (888) 982-4748; 
email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-10418 Filed 5-4-15; 8:45 am]
 BILLING CODE 4163-18-P